全文获取类型
收费全文 | 267606篇 |
免费 | 20461篇 |
国内免费 | 7413篇 |
专业分类
耳鼻咽喉 | 1911篇 |
儿科学 | 9510篇 |
妇产科学 | 2671篇 |
基础医学 | 23911篇 |
口腔科学 | 4798篇 |
临床医学 | 27678篇 |
内科学 | 61672篇 |
皮肤病学 | 3607篇 |
神经病学 | 29640篇 |
特种医学 | 7474篇 |
外国民族医学 | 296篇 |
外科学 | 21422篇 |
综合类 | 36075篇 |
现状与发展 | 33篇 |
一般理论 | 13篇 |
预防医学 | 21742篇 |
眼科学 | 3423篇 |
药学 | 19949篇 |
198篇 | |
中国医学 | 12912篇 |
肿瘤学 | 6545篇 |
出版年
2024年 | 232篇 |
2023年 | 4918篇 |
2022年 | 6727篇 |
2021年 | 12507篇 |
2020年 | 12421篇 |
2019年 | 11131篇 |
2018年 | 10908篇 |
2017年 | 9763篇 |
2016年 | 9622篇 |
2015年 | 9437篇 |
2014年 | 21573篇 |
2013年 | 22563篇 |
2012年 | 16860篇 |
2011年 | 17841篇 |
2010年 | 15433篇 |
2009年 | 14554篇 |
2008年 | 12769篇 |
2007年 | 11194篇 |
2006年 | 9775篇 |
2005年 | 8170篇 |
2004年 | 7030篇 |
2003年 | 6049篇 |
2002年 | 5036篇 |
2001年 | 4378篇 |
2000年 | 3725篇 |
1999年 | 3041篇 |
1998年 | 2614篇 |
1997年 | 2278篇 |
1996年 | 1990篇 |
1995年 | 2095篇 |
1994年 | 1947篇 |
1993年 | 1646篇 |
1992年 | 1534篇 |
1991年 | 1389篇 |
1990年 | 1110篇 |
1989年 | 943篇 |
1988年 | 875篇 |
1987年 | 796篇 |
1986年 | 681篇 |
1985年 | 1246篇 |
1984年 | 1172篇 |
1983年 | 752篇 |
1982年 | 903篇 |
1981年 | 769篇 |
1980年 | 604篇 |
1979年 | 545篇 |
1978年 | 442篇 |
1977年 | 362篇 |
1976年 | 334篇 |
1975年 | 275篇 |
排序方式: 共有10000条查询结果,搜索用时 265 毫秒
61.
目的 基于数据非依赖性采集的定量蛋白质组学技术(data independent acquisition,DIA)对稳定性冠心病血瘀证患者的血浆蛋白质进行研究分析,初步探索冠心病血瘀证的关键生物学过程与核心靶点。方法 选择中国中医科学院广安门医院心血管科收治的5例稳定性冠心病患者作为疾病观察组,同时选取健康成人5人作为对照组,采用DIA蛋白质组学技术对受试者的血浆进行检测,确定蛋白质表达量后进行差异蛋白质表达分析、GO富集分析、KEGG信号通路图查询和蛋白质互作网络分析。结果 在差异倍数为1.5倍时,疾病观察组相比于健康对照组,共鉴定到22个蛋白质下调,9个蛋白质上调。进一步的生物信息学分析表明,冠心病血瘀证的生物学过程与补体参与的慢性炎症反应有关,关键信号通路是补体与凝血级联反应的信号通路,核心蛋白质为C反应蛋白、转甲状腺素蛋白、补体因子H、维生素D结合蛋白等。结论 冠心病血瘀证的生物学过程与补体参与的慢性炎症反应有关。 相似文献
62.
Kevin Kyung Ho Choi Santosh Sanagapalli 《World journal of gastrointestinal oncology》2022,14(3):568-586
Barrett's esophagus (BE) is the precursor to esophageal adenocarcinoma (EAC). Progression to cancer typically occurs in a stepwise fashion through worsening dysplasia and ultimately, invasive neoplasia. Established EAC with deep involvement of the esophageal wall and/or metastatic disease is invariably associated with poor long-term survival rates. This guides the rationale of surveillance of Barrett’s in an attempt to treat lesions at an earlier, and potentially curative stage. The last two decades have seen a paradigm shift in management of Barrett’s with rapid expansion in the role of endoscopic eradication therapy (EET) for management of dysplastic and early neoplastic BE, and there have been substantial changes to international consensus guidelines for management of early BE based on evolving evidence. This review aims to assist the physician in the therapeutic decision-making process with patients by comprehensive review and summary of literature surrounding natural history of Barrett’s by histological stage, and the effectiveness of interventions in attenuating the risk posed by its natural history. Key findings were as follows. Non-dysplastic Barrett’s is associated with extremely low risk of progression, and interventions cannot be justified. The annual risk of cancer progression in low grade dysplasia is between 1%-3%; EET can be offered though evidence for its benefit remains confined to highly select settings. High-grade dysplasia progresses to cancer in 5%-10% per year; EET is similarly effective to and less morbid than surgery and should be routinely performed for this indication. Risk of nodal metastases in intramucosal cancer is 2%-4%, which is comparable to operative mortality rate, so EET is usually preferred. Submucosal cancer is associated with nodal metastases in 14%-41% hence surgery remains standard of care, except for select situations. 相似文献
63.
64.
65.
Clinical characteristics of pediatric patients with COVID-19 between Omicron era vs. pre-Omicron era
《Journal of infection and chemotherapy》2022,28(11):1501-1505
IntroductionDetailed data on clinical characteristics in children with the omicron strain of SARS-COV-2 are limited.MethodsWe conducted a retrospective observational study of children with COVID-19 at the National Center for Child Health and Development to evaluate the clinical manifestations during and before the emergence of the omicron variant. Only symptomatic patients without underlying diseases were included. Participants were divided into two temporal groups: the “omicron era” (1/2022–2/2022) and the “pre-omicron era,” where the delta variant predominated (7/2021–11/2021). The patients were subclassified into an older vaccine-eligible group (aged 12–17 years), a younger vaccine-eligible group (aged 5–11 years), and a vaccine-ineligible group (aged 0–4 years).ResultsWe compared 113 patients in the omicron era with 106 in the pre-omicron era. Most patients in both eras had non-severe disease, and no patients required mechanical ventilation or died. Among patients aged 0–4 years, sore throat and hoarseness were more common during the omicron era than the pre-omicron era (11.1% vs. 0.0% and 11.1% vs. 1.5%, respectively). Croup syndrome was diagnosed in all patients with hoarseness. Among patients aged 5–11 years, vomiting was more frequent during the omicron era (47.2%) than during the pre-omicron era (21.7%). Cough and rhinorrhea were less common during the omicron era in patients aged 0–4 and 5–11 years, respectively, than during the pre-omicron era.ConclusionsIn children with COVID-19, clinical manifestations differed between the omicron and pre-omicron eras. In the Omicron era, croup syndrome was more frequent in vaccine-ineligible children. 相似文献
66.
67.
68.
69.
70.